XML 14 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF INCOME (unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Dialysis patient service revenues $ 2,846,494 $ 2,837,940 $ 8,372,874 $ 8,370,484
Other revenues 102,200 100,379 320,132 304,346
Total revenues 2,948,694 2,938,319 8,693,006 8,674,830
Operating expenses:        
Patient care costs 2,085,555 2,008,589 6,120,872 5,912,196
General and administrative 365,447 293,095 975,486 872,612
Depreciation and amortization 194,414 170,462 538,534 505,852
Equity investment income, net (8,509) (8,704) (24,696) (23,785)
Total operating expenses 2,636,907 2,463,442 7,610,196 7,266,875
Operating income 311,787 474,877 1,082,810 1,407,955
Debt expense (99,680) (72,829) (256,057) (213,167)
Other (loss) income, net (4,898) (7,590) (7,968) 8,766
Income before income taxes 207,209 394,458 818,785 1,203,554
Income tax expense 42,515 74,704 163,757 241,224
Net income 164,694 319,754 655,028 962,330
Less: Net income attributable to noncontrolling interests (59,328) (60,000) (162,731) (171,353)
Net income attributable to DaVita Inc. $ 105,366 $ 259,754 $ 492,297 $ 790,977
Earnings per share attributable to DaVita Inc.:        
Basic net income $ 1.16 $ 2.48 $ 5.24 $ 7.41
Diluted net income $ 1.13 $ 2.36 $ 5.07 $ 7.08
Weighted average shares for earnings per share:        
Basic (in shares) 91,160,000 104,793,000 93,959,000 106,685,000
Diluted (in shares) 93,263,000 109,838,000 97,153,000 111,666,000